Technical Analysis for CNAT - Conatus Pharmaceuticals Inc.

Grade Last Price % Change Price Change
grade F 2.04 0.49% 0.01
CNAT closed up 0.49 percent on Friday, February 15, 2019, on 56 percent of normal volume.

Earnings due: Mar 6

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Down
See historical CNAT trend table...

Date Alert Name Type % Chg
Feb 15 20 DMA Support Bullish 0.00%
Feb 15 Narrow Range Bar Range Contraction 0.00%
Feb 15 Wide Bands Range Expansion 0.00%
Feb 14 Shooting Star Candlestick Bearish 0.49%
Feb 14 20 DMA Support Bullish 0.49%
Feb 14 Wide Bands Range Expansion 0.49%
Feb 13 20 DMA Support Bullish -0.97%
Feb 13 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -0.97%
Feb 13 Narrow Range Bar Range Contraction -0.97%
Feb 13 Inside Day Range Contraction -0.97%

Older signals for CNAT ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of medicines to treat liver diseases in the United States. Its products include Emricasan, an orally active caspase protease inhibitor for the treatment of acute-on-chronic liver failure and chronic liver failure, as well as for the patients who have developed liver fibrosis post-orthotopic liver transplant due to Hepatitis C virus infection. The company was founded in 2005 and is headquartered in San Diego, California.
Medicine Biotechnology Medical Specialties Healthcare Associated Infections Infectious Causes Of Cancer Hepatitis Hepatocellular Carcinoma Hepatology Hepatitis C Virus Infection Organ Transplantation Liver Liver Diseases Liver Fibrosis
Is CNAT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 7.95
52 Week Low 1.15
Average Volume 913,386
200-Day Moving Average 3.8839
50-Day Moving Average 1.8572
20-Day Moving Average 2.021
10-Day Moving Average 2.066
Average True Range 0.191
ADX 21.62
+DI 26.0756
-DI 15.9783
Chandelier Exit (Long, 3 ATRs ) 1.987
Chandelier Exit (Short, 3 ATRs ) 2.263
Upper Bollinger Band 2.3848
Lower Bollinger Band 1.6572
Percent B (%b) 0.53
BandWidth 36.001979
MACD Line -0.0067
MACD Signal Line -0.0161
MACD Histogram 0.0094
Fundamentals Value
Market Cap 61.21 Million
Num Shares 30 Million
EPS -0.98
Price-to-Earnings (P/E) Ratio -2.08
Price-to-Sales 7.70
Price-to-Book 4.00
PEG Ratio -0.23
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.15
Resistance 3 (R3) 2.14 2.11 2.13
Resistance 2 (R2) 2.11 2.08 2.11 2.12
Resistance 1 (R1) 2.07 2.06 2.06 2.08 2.12
Pivot Point 2.04 2.04 2.03 2.04 2.04
Support 1 (S1) 2.00 2.01 1.99 2.01 1.96
Support 2 (S2) 1.97 1.99 1.97 1.96
Support 3 (S3) 1.93 1.97 1.95
Support 4 (S4) 1.94